FDA Announces Class I Recall On Arrow International Cardiac Catheter Device
Executive Summary
The US FDA has announced a high-risk class I recall on a cardiac catheter from Teleflex Inc. subsidiary Arrow International due to the risk of tip damage during use.
You may also be interested in...
Class I Recall For Mislabeled Teleflex Catheters
The US FDA has designated a recall of nearly 2,000 cardiovascular catheter kits from Teleflex subsidiary Arrow International class I, its most serious type.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.